Observed perioperative mortality and annual adverse events for DAH in children in comparison to reported results of paediatric Ross procedures, mechanical AVR and standard allograft implantation in children
. | DAH . | Ross [18] . | Mechanical [10] . | Allograft [10] . |
---|---|---|---|---|
Early death (%) | 0.94 | 4.19 | 7.34 | 12.82 |
Late mortality (%/years) | 0.38 | 0.54 | 1.23 | 1.59 |
Reoperation and intervention (%/years) | 2 | 3.04 | 1.07 | 5.44 |
Structural valve degeneration (%/years) | 2.29 | 3.25 | 0.86 | 2.93 |
Thrombosis/bleeding (%/years) | 0 | 0.35 | 1.15 | 1.99 |
Endocarditis (%/years) | 0.29 | 0.27 | 0.45 | 0.66 |
. | DAH . | Ross [18] . | Mechanical [10] . | Allograft [10] . |
---|---|---|---|---|
Early death (%) | 0.94 | 4.19 | 7.34 | 12.82 |
Late mortality (%/years) | 0.38 | 0.54 | 1.23 | 1.59 |
Reoperation and intervention (%/years) | 2 | 3.04 | 1.07 | 5.44 |
Structural valve degeneration (%/years) | 2.29 | 3.25 | 0.86 | 2.93 |
Thrombosis/bleeding (%/years) | 0 | 0.35 | 1.15 | 1.99 |
Endocarditis (%/years) | 0.29 | 0.27 | 0.45 | 0.66 |
AVR: aortic valve replacement; DAH: decellularized aortic homografts.
Observed perioperative mortality and annual adverse events for DAH in children in comparison to reported results of paediatric Ross procedures, mechanical AVR and standard allograft implantation in children
. | DAH . | Ross [18] . | Mechanical [10] . | Allograft [10] . |
---|---|---|---|---|
Early death (%) | 0.94 | 4.19 | 7.34 | 12.82 |
Late mortality (%/years) | 0.38 | 0.54 | 1.23 | 1.59 |
Reoperation and intervention (%/years) | 2 | 3.04 | 1.07 | 5.44 |
Structural valve degeneration (%/years) | 2.29 | 3.25 | 0.86 | 2.93 |
Thrombosis/bleeding (%/years) | 0 | 0.35 | 1.15 | 1.99 |
Endocarditis (%/years) | 0.29 | 0.27 | 0.45 | 0.66 |
. | DAH . | Ross [18] . | Mechanical [10] . | Allograft [10] . |
---|---|---|---|---|
Early death (%) | 0.94 | 4.19 | 7.34 | 12.82 |
Late mortality (%/years) | 0.38 | 0.54 | 1.23 | 1.59 |
Reoperation and intervention (%/years) | 2 | 3.04 | 1.07 | 5.44 |
Structural valve degeneration (%/years) | 2.29 | 3.25 | 0.86 | 2.93 |
Thrombosis/bleeding (%/years) | 0 | 0.35 | 1.15 | 1.99 |
Endocarditis (%/years) | 0.29 | 0.27 | 0.45 | 0.66 |
AVR: aortic valve replacement; DAH: decellularized aortic homografts.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.